February 22 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday its consolidated net profit fell to 40.1 million levs ($25.0 million/20.5 million euro) in 2017 from 50.6 million levs the year before.
The drug maker's operating revenue increased to 1.03 billion levs last year, compared to 908.4 million levs in 2016, Sopharma said in an annual financial report.
Sales revenue rose to 1.02 billion levs in 2017 from 885.4 million levs the year before, while financial revenue fell to 8.4 million levs from 21.9 million levs.
Sopharma's total operating expenses grew to 980.9 million levs in 2017 from 855.3 million levs a year earlier.
Sopharma, Bulgaria's biggest pharmaceuticals producer, has subsidiaries in Moldova, Russia, Serbia, Belarus, Poland, Latvia, Lithuania, Ukraine and Kazakhstan.
As at 15:10 CET on Thursday, Sopharma shares traded flat at 4.12 levs.
(1 euro = 1.95583 levs)